Clinical research company Medpace Holdings (NASDAQ:MEDP) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 32% year on year to $708.5 million. The company expects …
Medpace (NASDAQ:MEDP) Reports Bullish Q4 CY2025
view original post